THROMBOCYTOPENIA IS A THROMBOTIC RISK FACTOR IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE?

被引：0
|
作者：
Demetrio Pablo, R. [1 ]
Munoz, P. [2 ]
Calvo-Rio, V. [3 ]
Riancho-Zarrabeitia, L. [3 ]
Lopez-Hoyos, M. [4 ]
Martinez-Taboada, V. M. [3 ]
机构：
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Ophtalmol, Santander, Spain
[2] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Primary Care Management, Santander, Spain
[3] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Rheumatol, Santander, Spain
[4] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Immunol, Santander, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5274
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0308
引用
收藏
页码：779 / 779
页数：1
相关论文
共 50 条
  • [1] Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria
    Demetrio Pablo, Rosalia
    Munoz, Pedro
    Lopez-Hoyos, Marcos
    Calvo, Vanesa
    Riancho, Leyre
    Manuel Martinez-Taboada, Victor
    MEDICINA CLINICA, 2017, 148 (09): : 394 - 400
  • [2] EVALUATION OF THROMBOTIC RISK IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE
    Pablo, R. Demetrio
    Munoz, P.
    Calvo-Rio, V.
    Riancho-Zarrabeitia, L.
    Lopez-Hoyos, M.
    Martinez-Taboada, V. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 548 - 548
  • [3] EVALUATION OF THROMBOTIC RISK IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA FOR THE DISEASE
    Demetrio-Pablo, R.
    Munoz, P.
    Calvo-Rio, V.
    Riancho-Zarrabeitia, L.
    Lopez-Hoyos, M.
    Martinez-Taboada, V.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S97 - S97
  • [4] THROMBOCYTOPENIA IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES: A PARADOXICAL THROMBOTIC RISK FACTOR
    Hisada, R.
    Kato, M.
    Sugawara, E.
    Ohmura, K.
    Nakagawa, I.
    Oku, K.
    Bohgaki, T.
    Amengual, O.
    Horita, T.
    Yasuda, S.
    Atsumi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 315 - 315
  • [5] Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopenia
    Moulinet, Thomas
    Dufrost, Virginie
    Clerc-Urmes, Isabelle
    Wahl, Denis
    Zuily, Stephane
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 84 : 101 - 103
  • [6] Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies
    Kim, Ki-Jo
    Baek, In-Woon
    Yoon, Chong-Hyeon
    Kim, Wan-Uk
    Cho, Chul-Soo
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (05) : 706 - 714
  • [7] Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies
    Orsi, Fernanda
    Saraiva, Sabrina
    Colella, Marina
    Hayakawa, Gabriela
    De Paula, Erich Vinicius
    Annichinno-Bizzachi, Joyce
    Cruz, Ana Clara
    LUPUS, 2019, 28 : 18 - 18
  • [8] Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies
    Ladeira Cruz, Ana Clara
    Colella, Marina Pereira
    De Paula, Erich Vinicius
    Annichinno-Bizzachi, Joyce
    Orsi, Fernanda Andrade
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 69 : E6 - E7
  • [9] Clinical Course of Primary Immune Thrombocytopenia with Positive Antiphospholipid Antibodies
    Cruz, Ana Clara
    Saraiva, Sabrina
    Colella, Marina Pereira
    Yamaguti Hayakawa, Gabriela G.
    De Paula, Erich Vinicius
    Annichino Bizzacchi, Joyce Maria
    Orsi, Fernanda Andrade
    BLOOD, 2018, 132
  • [10] The clinical significance of antiphospholipid antibodies in patients without autoimmune disease
    Brighton, TA
    Chesterman, CN
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 2000, 30 (06): : 693 - 703
12345